Summary of Binding at five sites: effective cholera inhibitor based on cholera toxins
An international team developed a novel cholera inhibitor using an inactive cholera toxin protein scaffold. This inhibitor effectively blocks the active toxin from binding to carbohydrates on intestinal cell surfaces, preventing infection by targeting five specific binding sites.
Parts used in Cholera Inhibitor Project:
- Inactive cholera toxin
- Protein scaffold
- Cholera toxin
- Carbohydrates on intestinal cells
(Phys.org) —Cholera against cholera: a novel inhibitor prevents the cholera toxin from binding to carbohydrates found on the surface of intestinal cells. An international team of researchers has described their elegant concept in the journal Angewandte Chemie: The protein scaffold of the inhibitor is based on an inactive cholera toxin
Read more here:
Binding at five sites: effective cholera inhibitor based on cholera toxins
-
How does the new inhibitor prevent cholera?
The inhibitor prevents the cholera toxin from binding to carbohydrates found on the surface of intestinal cells. -
What is the basis of the inhibitor's protein scaffold?
The protein scaffold of the inhibitor is based on an inactive cholera toxin. -
Does the inhibitor bind at multiple sites?
Yes, the effective inhibitor binds at five sites. -
Where was this concept described?
The researchers described their concept in the journal Angewandte Chemie. -
Can this inhibitor stop the toxin from binding?
Yes, the novel inhibitor prevents the cholera toxin from binding to carbohydrates. -
What type of cells are targeted by the carbohydrates?
The carbohydrates are found on the surface of intestinal cells.
